Salicylic Acid

Description

New_FootCure Foot Cream is presented in a box containing the topical formulation designed for application on the feet. The product is formulated to provide targeted relief and care for foot-related conditions. The cream's specific composition and active ingredients are designed to enhance skin health and comfort. The packaging ensures the integrity and stability of the formulation, facilitating ease of use and application.

Uses and Indications

This drug is indicated for the removal of corns and calluses. It provides relief from pain associated with these conditions by effectively removing the corns and calluses.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

Healthcare professionals are advised to apply a thin layer of the medication over the affected area twice daily, specifically in the morning and at night, or as directed by a physician. The application should be gently rubbed into the skin until it is completely absorbed.

Contraindications

Use is contraindicated in children under 2 years of age unless directed by a physician. Additionally, contact with the eyes should be strictly avoided to prevent potential irritation or injury.

Warnings and Precautions

For external use only. It is imperative to keep this product out of the reach of children to prevent accidental ingestion. In the event of swallowing, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

This product is not recommended for use in children under 2 years of age unless specifically directed by a healthcare professional.

Users should discontinue use and consult a physician if any irritation or allergic reaction occurs. Monitoring for these adverse effects is essential to ensure patient safety and appropriate management.

Side Effects

For external use only. Patients should discontinue use and consult a healthcare professional if irritation or an allergic reaction occurs.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions between the drug and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (salicylic acid 12%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should not use this medication unless specifically directed by a healthcare professional. Caution is advised when considering treatment options for this age group, and healthcare providers should evaluate the risks and benefits before prescribing.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Safety during pregnancy has not been established for this medication. It is not recommended for use during pregnancy due to potential risks to the fetus. Specifically, there may be risks associated with the use of salicylic acid during this period.

Healthcare providers should be consulted for advice regarding dosage modifications and the appropriateness of use during pregnancy. Women of childbearing potential should be informed of these risks and the importance of discussing any potential exposure with their healthcare provider.

Lactation

There are no specific warnings or recommendations regarding the use of salicylic acid cream in lactating mothers. Additionally, there is no information available concerning the potential for excretion of salicylic acid in breast milk or any associated risks to breastfed infants during the use of this cream.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Additionally, specific antidotes or treatments may be indicated depending on the substance involved in the overdose. Consultation with a poison control center or a medical toxicologist is recommended to guide management and ensure optimal patient care.

Overall, vigilance and prompt intervention are critical in managing cases of suspected overdose, even in the absence of detailed information regarding specific overdosage effects.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of the reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

It is important to inform patients that this product should not be used in children under 2 years of age unless directed by a doctor. Providers should emphasize the necessity of consulting a healthcare professional before use in this age group.

Patients should be counseled to stop using the product and to contact their doctor if they experience any irritation or signs of an allergic reaction. Additionally, healthcare providers should remind patients to avoid getting the product into their eyes during use.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, ensuring that it is protected from light exposure. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)